Salvador Martín Algarra-rekin lankidetzan egindako argitalpenak (7)

2004

  1. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients

    Bone Marrow Transplantation, Vol. 33, Núm. 5, pp. 499-502

  2. Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 27, Núm. 3, pp. 299-303

2003

  1. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer

    Oncology, Vol. 64, Núm. 1, pp. 28-35

2002

  1. Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer: A feasibility pilot study

    Oncology, Vol. 63, Núm. 3, pp. 254-265

  2. Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 4, pp. 347-353

  3. Second-line chemotherapy with irinotecan and vinorelbine in stage IIIb and IV non-small-cell lung cancer: A phase II study

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 5, pp. 480-484

1996

  1. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: Benefit for selected patients

    Bone Marrow Transplantation, Vol. 18, Núm. 1, pp. 143-149